查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
皮肤替代品市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按类型、按应用、最终用户、地区和竞争细分
市场调查报告书
商品编码
1326474

皮肤替代品市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按类型、按应用、最终用户、地区和竞争细分

Skin Substitutes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

由于对先进伤口护理产品的需求不断增长以及该领域的技术进步，全球皮肤替代品市场预计在预测期内将以惊人的速度增长。全球皮肤替代品市场是医疗行业快速增长的部分。皮肤替代品用于替代患者受损或缺失的皮肤，在烧伤、慢性伤口和其他皮肤损伤的治疗中变得越来越重要。据 Joye 律师事务所称，美国每年报告约 45 万起烧伤事故。在美国，约有 45,000 人因烧伤住院，其中约 25,000 人被送往专门的烧伤中心。

皮肤替代品的优点

皮肤替代品的主要优点之一是它们能够促进伤口癒合和预防感染。皮肤替代品能够在伤口上形成保护屏障，防止进一步损伤并让身体专注于癒合。它们还为新皮肤细胞的生长提供了框架，并有助于减少疤痕。皮肤替代品的另一个优点是其多功能性。皮肤替代品可用于多种医疗领域，并且可以定制以满足每个患者的需求。它们可用于治疗各种皮肤损伤，从小割伤和擦伤到大烧伤。此外，皮肤替代品是现代医学的一个重要方面，并已被证明在治疗严重皮肤损伤时可以挽救生命。它们可用于各种医疗领域，并可进行定制以满足每个患者的需求。皮肤替代品的发展彻底改变了皮肤损伤的治疗方法，并显着改善了患者的治疗效果。与皮肤替代品相关的所有这些优势预计将在未来几年推动全球皮肤替代品市场的增长。

干细胞在皮肤替代品中的应用

近年来，随着研究人员和医疗专业人员寻求提高这些产品在治疗一系列皮肤损伤方面的有效性，皮肤替代品领域出现了一些关键发展。这些开发旨在创造更有效、更通用、更易于使用的新产品，并可能在该领域的未来发挥重要作用。皮肤替代品领域的一项关键发展是干细胞的使用。干细胞是能够发育成体内许多不同类型细胞的细胞，并且有可能帮助再生受损或缺失的组织。研究人员一直在探索干细胞在皮肤替代品中的应用，并取得了有希望的结果。目前市场上的一些产品将干细胞融入皮肤替代品中，有助于提高癒合速度和质量。

3D 打印在皮肤替代品中的应用

3D 打印可以创建复杂的、定制设计的皮肤替代品，可以根据个别患者的需求进行定制。这项技术有可能彻底改变该领域，使製造高质量、有效的皮肤替代品变得更加容易，这些替代品用途更广泛、更易于使用。蓬勃发展的3D打印行业预计将在预测期内为全球皮肤替代品市场的增长创造新的前景。多年来，拥有集中式3D打印设施的医院数量从2010年的3家增加到2019年的100家。

个性化医疗日益普及

皮肤替代品领域的一个重要趋势是日益关注个性化医疗。多年来，个性化医疗的受欢迎程度显着增加。 2010年有36种药物可供使用，但到2020年已有286种药物可供使用。越来越多的个性化药物获得批准并在治疗不同类型的慢性和急性伤口方面越来越受欢迎，预计将为未来几年全球皮肤替代品市场的增长开闢新的前景。个性化医疗涉及皮肤替代品或伤口护理，涉及根据每位患者的个人需求定制治疗方案，并考虑年龄、性别和其他健康状况等因素。通过专注于个性化医疗，研究人员希望创造出更有效、更高效的皮肤替代品，有助于改善患者的治疗效果。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：临床试验分析

  • 正在进行的临床试验
  • 已完成的临床试验
  • 终止的临床试验
  • 按开发阶段分類的管道细目
  • 管道细分（按状态）
  • 按研究类型分類的管道细目
  • 按地区分類的管道明细
  • 临床试验热图

第 6 章：全球皮肤替代品市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型（生物与合成）
    • 按应用（急性伤口与慢性伤口）
    • 按最终用户（医院和诊所、门诊手术中心、其他）
    • 按地区
    • 按公司划分 (2022)
  • 产品图
    • 按类型
    • 按应用
    • 按最终用户
    • 按地区

第 7 章：北美皮肤替代品市场前景

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型（生物与合成）
    • 按应用（急性伤口与慢性伤口）
    • 按最终用户（医院和诊所、门诊手术中心、其他）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 8 章：欧洲皮肤替代品市场前景

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型（生物与合成）
    • 按应用（急性伤口与慢性伤口）
    • 按最终用户（医院和诊所、门诊手术中心、其他）
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 9 章：亚太皮肤替代品市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型（生物与合成）
    • 按应用（急性伤口与慢性伤口）
    • 按最终用户（医院和诊所、门诊手术中心、其他）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 10 章：南美洲皮肤替代品市场前景

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型（生物与合成）
    • 按应用（急性伤口与慢性伤口）
    • 按最终用户（医院和诊所、门诊手术中心、其他）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章：中东和非洲皮肤替代品市场前景

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按类型（生物与合成）
    • 按应用（急性伤口与慢性伤口）
    • 按最终用户（医院和诊所、门诊手术中心、其他）
    • 按国家/地区
  • MEA：国家分析
    • 南非皮肤替代品
    • 沙特阿拉伯皮肤替代品
    • 阿联酋皮肤替代品

第 12 章：市场动态

  • 司机
  • 挑战

第 13 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 14 章：全球皮肤替代品市场：SWOT 分析

第 15 章：波特的五力分析

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第16章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
    • Amarantus BioScience Holdings, Inc.
    • Organogenesis, Inc
    • Acelity LP, Inc.
    • Smith & Nephew plc
    • BSN Medical GmbH
    • Molnlycke Health Care ABss
    • Integra LifeSciences Corporation
    • Medtronic Plc
    • Tissue Regenix Ltd.
    • Stratatech Corporation

第 17 章：战略建议

简介目录
Product Code: 14831

Global Skin Substitutes Market is expected to grow at an impressive rate during the forecast period on account of the increasing demand for advanced wound care products and technological advancements in the field. Global Skin Substitutes Market is a rapidly growing segment of the medical industry. Skin substitutes, which are used to replace damaged or missing skin in patients, have become increasingly important in the treatment of burns, chronic wounds, and other skin injuries. According to Joye Law Firm, around 450,000 burn injuries are reported every year in the United States. Around 45,000 people are hospitalized because of burn injuries in the United States, of which about 25,000 are admitted to specialized burn centers.

The increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is one of the major factors driving the growth of the market. Additionally, the rising incidence of burns and other traumatic injuries is also contributing to the growth of the market. The annual incidence of diabetic foot ulcers worldwide is between 9.1 to 26.1 million. About 15 to 25% of patients suffering from diabetes mellitus tend to develop diabetic foot ulcers during their lifetime.

Skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. These substitutes are used to replace damaged or missing skin in patients and can be utilized in a variety of medical fields, including plastic surgery, dermatology, and burn care. Additionally, key developments in the field of skin substitutes, such as the use of advanced materials, such as nanofibers and hydrogels, and the development of new manufacturing techniques that allow for the creation of products that are more consistent and reliable. These advances are likely to lead to the creation of products that are more effective in treating a wider range of skin injuries. This, in turn, is expected to create lucrative opportunities for the growth of global skin substitutes market in the coming years.

Advantages Associated with Skin Substitutes

One of the major advantages of skin substitutes is their ability to promote wound healing and prevent infection. Skin substitutes are able to create a protective barrier over the wound, preventing further damage and allowing the body to focus on healing. They also provide a framework for new skin cells to grow and can help reduce scarring. Another advantage of skin substitutes is their versatility. Skin substitutes can be used in a variety of medical fields and can be customized to meet the needs of each patient. They can be used to treat a variety of skin injuries, from small cuts and scrapes to large burn injuries. Additionally, skin substitutes are an essential aspect of modern medicine and have proven to be lifesaving in the treatment of severe skin injuries. They can be used in a variety of medical fields and can be customized to meet the needs of each patient. The development of skin substitutes has revolutionized the treatment of skin injuries and has significantly improved patient outcomes. All these advantages associated with skin substitutes are expected to drive the growth of global skin substitutes market in the coming years.

Use of Stem Cells in the Skin Substitutes

The field of skin substitutes has seen several key developments in recent years as researchers and medical professionals seek to improve the effectiveness of these products in treating a range of skin injuries. These developments are aimed at creating new products that are more effective, more versatile, and easier to use and are likely to play an important role in the future of the field. One key development in the field of skin substitutes has been the use of stem cells. Stem cells are cells that have the ability to develop into many different types of cells in the body and have the potential to help regenerate damaged or missing tissue. Researchers have been exploring the use of stem cells in skin substitutes, with promising results. Some products on the market today incorporate stem cells into the skin substitute, helping to improve the speed and quality of healing.

Use of 3D Printing in the Skin Substitutes

3D printing allows for the creation of complex, custom-designed skin substitutes that can be tailored to the needs of individual patients. This technology has the potential to revolutionize the field, making it easier to create high-quality, effective skin substitutes that are more versatile and easier to use. The flourishing 3D printing industry is expected to create new prospects for the growth of global skin substitutes market during the forecast period. Over the years, the number of hospitals with a centralized 3D printing facility increased to 100 in 2019 from just three in 2010.

Growing Popularity of Personalized Medicine

One important trend in the field of skin substitutes is the increasing focus on personalized medicine. The popularity of personalized medicine has increased significantly over the years. In 2010 there were 36 medicines available, but in 2020 there were already 286 medicines available. The increasing number of personalized medicines getting approval and gaining popularity in terms of usage for the treatment of different kinds of chronic and acute wounds is expected to open new prospects for the growth of global skin substitutes market in the next few years. The involvement of personalized medicine in skin substitutes or wound care involves tailoring treatments to the individual needs of each patient and taking into account factors such as age, gender, and other health conditions. By focusing on personalized medicine, researchers hope to create skin substitutes that are more effective and efficient and that can help improve patient outcomes.

Market Segmentation

Global Skin Substitutes Market can be segmented by type, application, end-user, and by region. Based on type, global skin substitutes market can be divided into biological and synthetic. Biological skin substitutes can be further categorized into autografts, allografts, and xenografts. In terms of application, global skin substitutes can be categorized into acute wounds and chronic wounds. Based on end users, the global skin substitutes market can be segmented into hospitals & clinics, ambulatory surgery centers, and others. Regionally, the global skin substitutes market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. United States dominated the global skin substitute market in 2022 in terms of all the countries owing to the increasing number of people getting injured in fire accidents in the United States. Around 3,500 people get fatally injured in a fire or burn accident every year in the United States, requiring the use of skin substitutes for treatment purposes, thereby driving the growth of global skin substitutes market.

Market Players

Amarantus BioScience Holdings, Inc., Organogenesis, Inc, Acelity L.P., Inc., Smith & Nephew plc, BSN Medical GmbH, Molnlycke Health Care AB, Integra LifeSciences Corporation, Medtronic Plc, Tissue Regenix Ltd., Stratatech Corporation, among others, are some of the leading players operating in the global skin substitutes market. The field of skin substitutes has seen a number of exciting new product launches in recent years as companies develop new and innovative products designed to improve the treatment of a range of skin injuries. These product launches are aimed at creating new solutions that are more effective, more versatile, and easier to use and are likely to have a major impact on the future of the global skin substitute market.

  • In November 2022, AVITA Medical, Inc. announced that the U.S. Food and Drug Administration (FDA) had granted the company's autologous cellular therapy device for skin restoration, RECELL SYSTEM, a designation of breakthrough device. This breakthrough status will help in increasing access to RECELL SYSTEM for both patients and healthcare providers.
  • In August 2022, Organogenesis, Inc. announced that it had received U.S. Food and Drug Administration (FDA) 510k Clearance for PuraPly MZ. PuraPly MZ is based on the company's PuraPly technology, engineered into a micronized (powdered) form to provide surgeons with an option for complex surgical wounds.

Report Scope:

In this report, Global Skin Substitutes Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Skin Substitutes Market, By Type:

  • Biological
  • Autografts
  • Allografts
  • Xenografts
  • Synthetic

Skin Substitutes Market, By Application:

  • Acute Wounds
  • Chronic Wounds

Skin Substitutes Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Skin Substitutes Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Skin Substitutes Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Skin Substitute Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Biological v/s Synthetic)
      • 6.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 6.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 6.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Product Map
    • 6.3.1 By Type
    • 6.3.2 By Application
    • 6.3.3 By End User
    • 6.3.4 By Region

7. North America Skin Substitute Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Biological v/s Synthetic)
      • 7.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 7.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 7.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Skin Substitute Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Skin Substitute Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Skin Substitute Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Skin Substitute Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Biological v/s Synthetic)
      • 8.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 8.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 8.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Skin Substitute Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Skin Substitute Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Skin Substitute Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Skin Substitute Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Skin Substitute Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Skin Substitute Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Biological v/s Synthetic)
      • 9.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 9.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 9.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Skin Substitute Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Skin Substitute Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Skin Substitute Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Skin Substitute Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Skin Substitute Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Skin Substitute Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Biological v/s Synthetic)
      • 10.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 10.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 10.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Skin Substitute Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Skin Substitute Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Skin Substitute Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Skin Substitute Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Biological v/s Synthetic)
      • 11.2.1.1. By Biological (Autografts, Allografts, Xenografts)
    • 11.2.2. By Application (Acute Wounds v/s Chronic Wounds)
    • 11.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Skin Substitute Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Skin Substitute Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Skin Substitute Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Development
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Skin Substitute Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Product Offerings
  • 16.3. Recent Developments
  • 16.4. Financials (As Reported)
  • 16.5. Key Personnel
    • 16.5.1. Amarantus BioScience Holdings, Inc.
    • 16.5.2. Organogenesis, Inc
    • 16.5.3. Acelity L.P., Inc.
    • 16.5.4. Smith & Nephew plc
    • 16.5.5. BSN Medical GmbH
    • 16.5.6. Molnlycke Health Care ABss
    • 16.5.7. Integra LifeSciences Corporation
    • 16.5.8. Medtronic Plc
    • 16.5.9. Tissue Regenix Ltd.
    • 16.5.10. Stratatech Corporation

17. Strategic Recommendations